154 related articles for article (PubMed ID: 16627922)
1. Angiogenesis in craniopharyngiomas: Microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin.
Dallago CM; Oliveira MC; Barbosa-Coutinho LM; Ferreira NP
Endocr Pathol; 2005; 16(4):355-62. PubMed ID: 16627922
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome.
Vidal S; Kovacs K; Lloyd RV; Meyer FB; Scheithauer BW
Cancer; 2002 Feb; 94(3):738-45. PubMed ID: 11857307
[TBL] [Abstract][Full Text] [Related]
4. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and the growth potential of craniopharyngiomas.
Vidal S; Scheithauer BW; Kovacs K; Lloyd RV
Endocr Pathol; 2005; 16(3):219-28. PubMed ID: 16299405
[TBL] [Abstract][Full Text] [Related]
6. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
7. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
8. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
9. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs.
Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C
J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314
[TBL] [Abstract][Full Text] [Related]
10. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
[TBL] [Abstract][Full Text] [Related]
11. Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngioma.
Xu J; Zhang S; You C; Wang X; Zhou Q
Surg Neurol; 2006; 66 Suppl 1():S30-4. PubMed ID: 16904996
[TBL] [Abstract][Full Text] [Related]
12. Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.
Zhang J; Zhang M; Li X; Zheng T; Mu G; Liu W; Xie H; Liu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):560. PubMed ID: 21823022
[TBL] [Abstract][Full Text] [Related]
13. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
[TBL] [Abstract][Full Text] [Related]
14. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
[TBL] [Abstract][Full Text] [Related]
16. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
Pizarro CB; Oliveira MC; Pereira-Lima JF; Leães CG; Kramer CK; Schuch T; Barbosa-Coutinho LM; Ferreira NP
Neuropathology; 2009 Feb; 29(1):40-4. PubMed ID: 18673444
[TBL] [Abstract][Full Text] [Related]
18. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]